Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02264613
Title Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Aileron Therapeutics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham Alabama 35294 United States Details
Duarte California 91010 United States Details
Denver Colorado 80218 United States Details
Sarasota Florida 34232 United States Details
Tampa Florida 33612 United States Details
Boston Massachusetts 02114 United States Details
Boston Massachusetts 02215 United States Details
Bronx New York 10461 United States Details
New York New York 10065 United States Details
Greenville South Carolina 29605 United States Details
Nashville Tennessee 37203 United States Details
Houston Texas 77030 United States Details
Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field